Deutsche Bank Aktiengesellschaft Raises Bath & Body Works (NYSE:BBWI) Price Target to $22.00

Bath & Body Works (NYSE:BBWI) had its price target upped by Deutsche Bank Aktiengesellschaft from $21.00 to $22.00 in a research note issued on Tuesday,MarketScreener reports. The firm presently has a “hold” rating on the stock. Deutsche Bank Aktiengesellschaft’s target price points to a potential downside of 4.10% from the stock’s current price.

A number of other equities research analysts also recently issued reports on BBWI. Zacks Research upgraded shares of Bath & Body Works from a “strong sell” rating to a “hold” rating in a research note on Tuesday, January 20th. Citigroup downgraded shares of Bath & Body Works from a “buy” rating to a “neutral” rating and boosted their price target for the stock from $21.00 to $25.00 in a report on Tuesday, February 17th. Guggenheim assumed coverage on shares of Bath & Body Works in a report on Tuesday, December 9th. They set a “neutral” rating for the company. UBS Group increased their price objective on Bath & Body Works from $21.00 to $22.00 and gave the company a “neutral” rating in a report on Monday, February 23rd. Finally, Jefferies Financial Group started coverage on Bath & Body Works in a research report on Wednesday, January 14th. They set a “hold” rating and a $24.00 price target on the stock. Three equities research analysts have rated the stock with a Buy rating and fourteen have issued a Hold rating to the stock. Based on data from MarketBeat.com, Bath & Body Works presently has a consensus rating of “Hold” and a consensus price target of $23.86.

Bath & Body Works Trading Up 2.3%

BBWI opened at $22.94 on Tuesday. Bath & Body Works has a 1-year low of $14.27 and a 1-year high of $35.21. The company has a market cap of $4.70 billion, a price-to-earnings ratio of 7.06, a PEG ratio of 0.97 and a beta of 1.48. The company’s fifty day moving average price is $22.32 and its two-hundred day moving average price is $23.59.

Bath & Body Works (NYSE:BBWI) last posted its earnings results on Wednesday, March 4th. The company reported $2.05 EPS for the quarter, topping the consensus estimate of $1.77 by $0.28. The company had revenue of $2.72 billion during the quarter, compared to the consensus estimate of $2.59 billion. Bath & Body Works had a net margin of 9.50% and a negative return on equity of 47.35%. The firm’s revenue for the quarter was down 2.3% on a year-over-year basis. During the same period in the previous year, the firm posted $2.09 earnings per share. Bath & Body Works has set its Q1 2026 guidance at 0.240-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. As a group, equities analysts forecast that Bath & Body Works will post 3.3 earnings per share for the current fiscal year.

Institutional Trading of Bath & Body Works

Several institutional investors and hedge funds have recently bought and sold shares of BBWI. Royal Bank of Canada raised its position in shares of Bath & Body Works by 92.8% in the first quarter. Royal Bank of Canada now owns 59,877 shares of the company’s stock worth $1,815,000 after buying an additional 28,815 shares in the last quarter. Goldman Sachs Group Inc. increased its stake in Bath & Body Works by 15.7% in the first quarter. Goldman Sachs Group Inc. now owns 645,970 shares of the company’s stock valued at $19,586,000 after acquiring an additional 87,529 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its position in Bath & Body Works by 7.0% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 562,757 shares of the company’s stock valued at $17,063,000 after purchasing an additional 36,684 shares in the last quarter. Intech Investment Management LLC bought a new stake in Bath & Body Works during the first quarter worth about $1,155,000. Finally, Geneos Wealth Management Inc. increased its position in shares of Bath & Body Works by 217.7% during the 1st quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock valued at $35,000 after purchasing an additional 801 shares during the last quarter. 95.14% of the stock is currently owned by hedge funds and other institutional investors.

Key Stories Impacting Bath & Body Works

Here are the key news stories impacting Bath & Body Works this week:

• Positive Sentiment: Q4 beat on the top and bottom lines: adjusted EPS $2.05 vs. consensus ~$1.77 and revenue $2.72B vs. ~$2.59B; markets interpreted the beat as evidence the turnaround can work, helping shares trade higher. Bath & Body Works shares rise as Q4 beats estimates
• Positive Sentiment: Management says its “Consumer First” strategy and product/brand refocus are making progress, signaling potential medium‑term margin and sales benefits if execution continues — but they warned the shift will take time. Bath & Body Works Says Strategy Shift Making Progress But ‘Will Take Time’
• Neutral Sentiment: Analyst action: Deutsche Bank nudged its price target slightly higher to $22 (maintained Hold), a modest signal but not a clear catalyst. Deutsche Bank adjusts PT to $22 from $21
• Neutral Sentiment: Earnings call / analysis coverage published (transcript and quick takes) — useful for detail on same-store trends, promotions and inventory but largely confirm management’s cautious tone. Bath & Body Works Charts Turnaround Amid 2026 Squeeze
• Negative Sentiment: Guidance disappointed: FY 2026 EPS guide of $2.40–$2.65 below consensus (~$2.74) and Q1 guide of $0.24–$0.30 far below expectations — this is the primary near‑term negative catalyst as it signals tougher comps and a slower recovery. Company press release with results and 2026 guidance
• Negative Sentiment: Management warned annual sales will decline more steeply as consumers cut back on discretionary home‑fragrance and premium items — a demand risk that could pressure revenue and margins. Bath & Body Works forecasts steeper decline in annual sales (Reuters)
• Negative Sentiment: Legal risk: multiple law firms have filed or announced investigations/class actions alleging securities issues covering a June 2024–Nov 2025 period; this raises potential litigation costs, distraction and overhang on the stock. Bragar Eagel & Squire investor alert on BBWI

About Bath & Body Works

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.